DPA
DGX icon

Delphi Private Advisors’s Quest Diagnostics DGX Stock Holding History

Delphi Private Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10
Closed -$1K – 155
2016
Q4 		$1K Sell
10
-15
-60% -$1.29K ﹤0.01% 215
2016
Q3 		$2K Hold
25
– – ﹤0.01% 250
2016
Q2 		$2K Buy
25
+15
+150% +$1.14K ﹤0.01% 259
2016
Q1 		$1K Hold
10
– – ﹤0.01% 260
2015
Q4 		$1K Buy
+10
New +$672 ﹤0.01% 304

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Delphi Private Advisors's DGX Position: Q1 2017 in Review

Delphi Private Advisors sold out of Quest Diagnostics (DGX) in Q1 2017, closing a stake of 10 shares — an estimated $1K sold.

Delphi Private Advisors first reported a position in DGX in Q4 2015 and held it in 5 quarters. The position peaked at $2K in Q3 2016. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.

  • Delphi Private Advisors reported no remaining Quest Diagnostics position as of Q1 2017 after selling out during the quarter.
  • Delphi Private Advisors sold 10 Quest Diagnostics shares in Q1 2017, an estimated $1K.
  • Delphi Private Advisors first reported a position in Quest Diagnostics in Q4 2015 and held it in 5 quarters.
  • Delphi Private Advisors's Quest Diagnostics position peaked at $2K in Q3 2016.
  • 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.